A study of “total therapy” of acute lymphocyticleukemia in children†,††
References (21)
- et al.
Temporary remission in acute leukemia in children produced by folic acid antagonist 4-aminopteroyl glutamic acid (Aminopterin)
New England J. Med.
(1948) - et al.
Induction of remission in acute leukemia of childhood by combination of prednisone and either 6-mercaptopurine or methotrexate
J. Pediat.
(1966) - et al.
The effect of 6-mercaptopurine on the duration of steroid-induced remissions in acute leukemia: A model for evaluation of other potentiallyuseful therapy
Blood
(1963) - et al.
Studies of sequential and combination antimetabolite therapy in acute leukemia: 6-mercaptopurine and methotrexate
Blood
(1961) Implications of long-term survival in acute stem cell leukemia of childhood treated with composite cyclic therapy
Blood
(1964)Leukemia and lymphoma in children
Pediat. Clin. North America
(1959)- et al.
The effectiveness of combinations of antileukemic agents in inducing and maintaining remission in children with acute leukemia
Blood
(1965) Hemorrhagic cystitis and cyclophosphamide
Lancet
(1963)Blood diseases of infancy and childhood
- et al.
New treatment schedule with improved survival in childhood leukemia. Intermittent parenteral vs. daily oral administration of methotrexate for maintenance of induced remission
J. A. M. A.
(1965)
There are more references available in the full text version of this article.
Cited by (0)
- †
Presented in part before the Fifty-Seventh Annual Meeting of the American Association for Cancer Research, Denver, Colo., May 26, 1966.
- ††
Supported by Research Grants CA 07594,CA 05176, and CA 08480 from the National Cancer Institute, National Institutes of Health, Public health Service, and by the American Lebanese Syrian Associated Charities.
- *
National Cancer Institute, National Institutes ofHealth, Public Health Service. Present address, Department of Pediatrics, University of Tennessee College of Medicine, 860 Madison Ave., Memphis, Tenn. 38103.
Copyright © 1968 Published by Mosby, Inc.